Navigation Links
More Evidence That HPV Vaccine Shields Against Cervical Cancer
Date:11/9/2011

WEDNESDAY, Nov. 9 (HealthDay News) -- A new study suggests that the Cervarix cervical cancer vaccine may provide "excellent" protection against a precancerous lesion that is often a forerunner to invasive cervical cancer.

Cervarix, made by GlaxoSmithKline, protects against human papillomavirus (HPV) types 16 and 18, which cause 70 percent of cervical cancers. The vaccine is particularly effective when given to adolescent girls before they become sexually active.

Cervarix is one of two HPV vaccines approved by the U.S. Food and Drug Administration, the other being Merck's Gardasil.

The four-year study included nearly 20,000 women aged 15 to 25 in 14 countries in North America, Latin America, the Asia-Pacific region and Europe. The vaccine was found to be more than 93 percent effective against the CIN3 lesion, a precancerous anomaly that often appears before invasive cancer.

The vaccine was 100 percent effective against cancer in young women who were not infected with HPV before they were immunized, the study found, and it was 46 percent effective against CIN3 and 77 percent effective against cancer in the general population of women (who may or may not have been previously exposed to HPV).

Cervarix was 100 percent effective against CIN3 lesions specifically linked to the HPV 16 and HPV 18 strains in previously unexposed women, and it was nearly 46 percent effective in the general population.

The study appears online Nov. 8 in The Lancet Oncology.

One expert said the new findings "are further evidence of the benefits of HPV vaccine."

Dr. Stephanie V. Blank, an assistant professor in clinical gynecologic oncology at NYU School of Medicine, said, "Although not perfect, this study is the largest trial of HPV 16/18 vaccine to date. It is significant because with longer time of follow-up, we are better able to show the true effect of the vaccine."

Blank added that the study "shows that the HPV vaccine will be most protective among adolescent girls but that it is also effective among HPV-exposed women."

Along with specifically targeting HPV 16 and 18, Cervarix also partially protects against four other types of HPV (31, 33, 45 and 51) that account for 15 percent of cervical cancers, according to another study in the same issue of the journal.

Increasing vaccination rates, particularly among young females who aren't sexually active, should be a focus of HPV vaccination efforts, Dr. Mark Schiffman and Sholom Wacholder of the U.S. National Cancer Institute stressed in an accompanying commentary.

Blank agreed with that assessment. "There are several take-home messages here: Vaccinate early; catch-up programs are also worth it; the positive impact of the HPV vaccine may be even more than we had expected; and the vaccine has an effect even if a woman is already exposed to HPV," she said.

More information

The U.S. National Cancer Institute has more about HPV vaccines.

-- Robert Preidt

SOURCES: Stephanie V. Blank, MD, assistant professor, clinical gynecologic oncology, NYU School of Medicine, New York City; The Lancet Oncology, news release, Nov. 4, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Evidence base for exercise programs for older people still in the balance
2. Weak evidence to support exercise referrals
3. Little Evidence of Heart Risks From ADHD Meds
4. More Evidence Shows Newer Forms of Pill Raise Clot Risk, FDA Says
5. Clinical trial shows first evidence that anal cancer is preventable
6. Researchers have found evidence for the existence of a hypnotic state
7. More Evidence Links Tanning Beds to Higher Skin Cancer Risk
8. Evidence-based medicine in health-care reform
9. More evidence that allergies may help in fighting brain tumors
10. Toronto researchers find first physical evidence bilingualism delays onset of Alzheimers symptoms
11. Evidence Lacking That Cognitive Rehab Therapy Helps Brain-Injured Vets
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
More Evidence That HPV Vaccine Shields Against Cervical Cancer
(Date:5/2/2016)... ... May 02, 2016 , ... Marshall Votta, Josh Holmes and Laura ... development roles to drive RowdMap Inc.’s market growth across both health plans and provider ... order to succeed in value based care. , Marshall Votta joins RowdMap, Inc. as ...
(Date:5/1/2016)... , ... May 01, 2016 , ... ProBrand Reveal Volume 2 is a set of ... ProBrand Reveal Volume 2 keyframeless animations, users can easily create a unique logo reveal in ... feel of the various presets. Use these title presets to add a uniquely animated logo ...
(Date:4/30/2016)... ... April 30, 2016 , ... ... Talk Radio with Hypnotherapist, Mary O'Maley. What is hypnosis and hypnotherapy and ... (substances, smoking, weight control), pain relief (chronic and acute), birthing processes and medical ...
(Date:4/30/2016)... Santa Rosa, CA (PRWEB) , ... April 30, 2016 , ... “Aging well is a challenge for all of us, ... says NCMA’s Dr. Parul T. Kohli . “Research is showing more and more that ... the risk of disease and disability as we age.” Top priorities Dr. Kohli’s recommends for her ...
(Date:4/29/2016)... ... April 29, 2016 , ... Since launching ... national charitable foundation serving the footwear industry, has broken all previous participation records ... 130 companies across 23 states during the months of April and May, the ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... Jersey , April 29, 2016 ... Suite for Life Sciences, Product Development Capabilities in ... Life Science Customer Base . ... provider, today announced the acquisition of Skura Corporation,s ... global leader in adaptive sales enablement technology for ...
(Date:4/29/2016)... 2016 Automation is one of ... to the growing demands for productivity in speed, accuracy, ... systems are already adept of a wide range of ... manual labor. Instrumentation continues to evolve, and is poised ... a few years ago. Originally used mostly by the ...
(Date:4/28/2016)... -- Research and Markets has announced the ... 2016-2020" report to their offering.      ... global plastic surgery products market is expected to grow ... , ,The growing adoption of laser in aesthetics is ... market. Lasers are used to treat a broad range ...
Breaking Medicine Technology: